Koninklijke Philips N.V.
Research Koninklijke Philips N.V. (PHG) on Bullrun: valuation model: 15.4% undervalued, market cap USD 25.90B, P/E 23.3, dividend yield 3.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPHG
- ExchangeNYSE
- CountryNetherlands
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal15.4% undervalued
- Market capUSD 25.90B
- P/E23.3
- Dividend yield3.7%
- Financial periodQ1 2026
- RevenueUSD 3.91B
- Net incomeUSD 970.00M
- Free cash flowUSD 1.62B
- Gross margin204.2%
Valuation Snapshot
Bullrun's latest valuation model marks Koninklijke Philips N.V. as 15.4% undervalued; latest market cap is USD 25.90B; P/E is 23.3; dividend yield is 3.7%.
About Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices.
Frequently asked questions
Is Koninklijke Philips N.V. overvalued or undervalued?
Bullrun's valuation model currently marks Koninklijke Philips N.V. as 15.4% undervalued.
What is Koninklijke Philips N.V.'s market cap?
Koninklijke Philips N.V.'s market capitalization is USD 25.90B.
What is Koninklijke Philips N.V.'s P/E ratio?
Koninklijke Philips N.V.'s price-to-earnings (P/E) ratio is 23.3.
Does Koninklijke Philips N.V. pay a dividend?
Koninklijke Philips N.V. has a dividend yield of 3.7%.
What does Koninklijke Philips N.V. do?
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments.